Boston Scientific Corp. (NYSE:BSX) garnered two upgrades and one downgrade from analysts this week, creating a roller-coaster effect in stock prices for the medical device giant. The company’s stock has been closing at higher and …
BSX had viewed LAAC as a global market opportunity of about $500M by 2019 and we believed the market was …
The stock markets in the United States declined again on Friday ... Partners agreed to provide a $150 million loan as part of its strategic partnership. Boston Scientific Corporation (NYSE:BSX) gained more than 2% to $13.01 per share after …
Boston Scientific Corp. (BSX), Monday said it stopped shipment of its top selling implantable cardioverter defibrillators, as it found some of the manufacturing process changes made were not submitted for approval with the US Food and Drug …
The hedge fund now owns almost $300 million in BSX stock, making the medical technology company its largest holding. According to Marketfolly, Greenlight's six largest disclosed long positions are Arkema, Boston Scientific, CIT Group, …
Perry Ellis Int'l (NASDAQ: PERY) 14.8% LOWER; expects total Q4 revenue to be approximately $218 million, versus …
Boston Scientific, which expects to complete its acquisition of Guidant shortly, said yesterday that its first-quarter earnings fell 7.3 percent on slower sales of devices used to treat clogged coronary arteries. But the company, a maker …
Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks during the recent roller coast on Wall Street, coming in at more than 120 million trades during the week ending July 29 and topping 140 …
... Scientific Corp (BSX.N) rose 6.8 percent after the closing bell on Monday after the company reported results. Its shares were trading at $11 after closing on the New York Stock Exchange at $10.30. Our Standards:The Thomson Reuters …
J.’s injury,” he wrote. Johnson & Johnson has moved on from the deal. It received a $705 million breakup fee from Boston Scientific. Since 2004, Johnson & Johnson’s stock has soared 83 percent, and the company is now worth $288 billion. …